Literature DB >> 32979204

Generation and Characterization of Mouse Models for Skeletal Disease.

Gabrielle E Foxa1, Ye Liu1, Lisa M Turner2, Alexander G Robling3,4,5, Tao Yang1, Bart O Williams6.   

Abstract

Our laboratories have used genetically engineered mouse models (GEMMs) to assess genetic contributions to skeletal diseases such as osteoporosis and osteoarthritis. Studies on the genetic contributions to OA are often done by assessing how GEMMs respond to surgical methods that induce symptoms modeling OA. Here, we will describe protocols outlining the induction of experimental OA in mice as well as detailed descriptions of methods for analyzing skeletal phenotypes using micro-computerized tomography and skeletal histomorphometry.

Entities:  

Keywords:  Histomorphometry; Osteoarthritis; microCT

Mesh:

Year:  2021        PMID: 32979204      PMCID: PMC7934896          DOI: 10.1007/978-1-0716-0989-7_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

Review 1.  Guidelines for assessment of bone microstructure in rodents using micro-computed tomography.

Authors:  Mary L Bouxsein; Stephen K Boyd; Blaine A Christiansen; Robert E Guldberg; Karl J Jepsen; Ralph Müller
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

2.  Osteoarthritis severity is sex dependent in a surgical mouse model.

Authors:  H-L Ma; T J Blanchet; D Peluso; B Hopkins; E A Morris; S S Glasson
Journal:  Osteoarthritis Cartilage       Date:  2007-01-03       Impact factor: 6.576

3.  Using mouse genetics to understand human skeletal disease.

Authors:  Scott E Youlten; Paul A Baldock
Journal:  Bone       Date:  2019-02-15       Impact factor: 4.398

4.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

5.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse.

Authors:  S S Glasson; M G Chambers; W B Van Den Berg; C B Little
Journal:  Osteoarthritis Cartilage       Date:  2010-10       Impact factor: 6.576

6.  Osteoarthritis development in novel experimental mouse models induced by knee joint instability.

Authors:  S Kamekura; K Hoshi; T Shimoaka; U Chung; H Chikuda; T Yamada; M Uchida; N Ogata; A Seichi; K Nakamura; H Kawaguchi
Journal:  Osteoarthritis Cartilage       Date:  2005-07       Impact factor: 6.576

Review 7.  CRISPR/CAS9 Technologies.

Authors:  Bart O Williams; Matthew L Warman
Journal:  J Bone Miner Res       Date:  2017-02-23       Impact factor: 6.741

8.  The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse.

Authors:  S S Glasson; T J Blanchet; E A Morris
Journal:  Osteoarthritis Cartilage       Date:  2007-04-30       Impact factor: 6.576

9.  Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome.

Authors:  Rajendra Kedlaya; Shreya Veera; Daniel J Horan; Rachel E Moss; Ugur M Ayturk; Christina M Jacobsen; Margot E Bowen; Chris Paszty; Matthew L Warman; Alexander G Robling
Journal:  Sci Transl Med       Date:  2013-11-13       Impact factor: 17.956

10.  Early Changes of Articular Cartilage and Subchondral Bone in The DMM Mouse Model of Osteoarthritis.

Authors:  Hang Fang; Lisi Huang; Ian Welch; Chris Norley; David W Holdsworth; Frank Beier; Daozhang Cai
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.